Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? SARS-CoV-2 and Hemoglobinopathies

Main Article Content

Lorenza Torti
a:1:{s:5:"en_US";s:93:"Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome, Italy";}

Laura Maffei
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) , Rome Italy

Francesco Sorrentino
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome, Italy

Paolo De Fabritiis
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome, Italy

Rossella Miceli
Ophthalmogy Department S. Eugenio Hospital/CTO, Rome , Italy

Elisabetta Abruzzese
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome, Italy

Keywords

SARS-CoV-2, thalassemia;, hemoglobinopathies;, infection;, epidemiology

Abstract

Not required for Letters

Downloads

Download data is not yet available.


Abstract 1165
PDF Downloads 735
HTML Downloads 324

References

REFERENCES

1. Galimberti S, Baldini C, Baratè C, Ricci F, Balducci S, Grassi S,et al. The CoV-2 outbreak: how hematologists could help to fight Covid-19. Pharmacol Res. 2020 May 6:104866. doi: 10.1016/j.phrs.2020.104866. https://doi: 10.1016/j.phrs.2020.104866. Epub 2020 May 6.PMID: 32387301
2. Groneberg D, Hilgenfeld R, Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research volume 6, Article number: 8 (2005) .https:// doi: 10.1186/1465-9921-6-8. PMID: 15661082
3. Menachery VD, Mitchell HD, Cockrell AS, Gralinski LE, Yount BL Jr, Graham RL, et al. MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis. mBio. 2017 Aug 22;8(4).https:// doi: 10.1128/mBio.00665-17.
4. Liu W, Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv March 2020.
5. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Mar 26. pii: S0923-7534(20)36383-3. https://doi: 10.1016/j.annonc.2020.03.296.
6. Seisdedos B, Gil D, Blouin, J.-M., E. & Millet, O. Protein Homeostasis Diseases .389-413.(Elsevier, 2020).
7. Vento S, Cainelli F, Cesario F. Infections and thalassemia. Lancet Infect Dis 2006,6:226-33. PMID: 16554247 https://DOI: 10.1016/S1473-3099(06)70437-6 .

8. Tahir F, Ahmed J, Malik F. Post-splenectomy Sepsis: A Review of the Literature. Cureus. 2020;12(2):e6898. 2020 Feb 6. https://doi:10.7759/cureus.6898.
9. Roy NBA, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F, et al. National Haemoglobinopathy Panel. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. Br J Haematol. 2020 Apr 24. https://doi: 10.1111/bjh.16687.
10. De Sanctis V, Kattamis C, Canatan D, Soliman A, Elsedfy H, Karimi M, et al. ?-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. MJHID 2017;9; e2017018. PMID:28293406
https://DOI: 10.4084/MJHID.2017.018
11. Silvestroni E, Bianco I. New statistical study on microcythemia in certain parts of the province of Ferrara and in the province of Rovigo. Prog Med (Napoli). 1952 Dec 31;8(24):760-3.
12. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017 Apr 20;376(16):1561-1573.https:// doi: 10.1056/NEJMc1706325. PMID: 28723338
13. Web Reference: https://www.statista.com/statistics/1104709/coronavirus-deaths-worldwide-per-milion-inhabitants/. For this statistic, numbers reported by Johns Hopkins University have been compared with the latest available population numbers.
14. Rivieccio BA, Luconi E, Boracchi P, Pariani E, Romanò L, Salini S, Castaldi S, Biganzoli E, Galli M. Heterogeneity of COVID-19 outbreak in Italy. Acta Bio Med [Internet]. 2020Apr.20 [cited 2020May15];91(2):31. PMID: 32420921 https://DOI: 10.23750/abm.v91i2.9579
15. Karimi M, Haghpanah S, Azarkeivan A, Zahedi Z, Zarei T, Akhavan Tavakoli M, Bazrafshan A, Shirkavand A, De Sanctis V. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in ?-Thalassemias: The Nationwide Iranian Experience. Br J Haematol. 2020;10.1111/bjh.16911. https://doi:10.1111/bjh.16911
16. Lansiaux E., Pebay P, Picard JL and Son-Forget J. COVID-19: Beta-Thalassemia Subjects Immunised?. Med Hypotheses. 2020 May 12;142:109827. PMCID: PMC7217120
https://DOI: 10.1016/j.mehy.2020.109827

Article Sidebar

PDF HTML
Published
Jun 28, 2020
DOI https://doi.org/10.4084/mjhid.2020.052

Article Details

How to Cite

Torti, L. (2020) “Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? SARS-CoV-2 and Hemoglobinopathies”, Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020052. doi: 10.4084/mjhid.2020.052.
Issue
Vol. 12 No. 1 (2020): Mediterranean Journal of Hematology and Infectious Diseases, Volume 12, 2020
Section
Letters to the Editor

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.